• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Updates, 09-01-2026: General Updates

    09-01-2026 | 03:18 pm

    Aurobindo Pharma's subsidiary, CuraTeQ Biologics, received Health Canada approval for its biosimilar Dyrupeg™. This expands market access, following 2025 EU and UK authorizations. Three additional biosimilars are currently under Health Canada review.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited